Orbimed Asia Partners III, L.P.
OrbiMed · adviser of record: Orbimed Advisors LLC · 2016 vintage
Orbimed Asia Partners III, L.P. is a 2016 venture fund managed by OrbiMed, with $540mm raised (Form D, amount sold). It reported $1.8bn in gross assets at year-end 2023, 3.33x its size, its highest reported value.
- Latest value held
- $1.8bn year-end 2023
- Peak
- $1.8bn year-end 2023
- Fund size
- $540mm Form D, amount sold
- Held vs. size
- 3.33x peak 3.33x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2023 | $1.8bn | 3.33x | +45% |
| 2022 | $1.24bn | 2.30x | +3% |
| 2021 | $1.21bn | 2.23x | +35% |
| 2020 | $896mm | 1.66x | +40% |
| 2019 | $640mm | 1.19x | +12% |
| 2018 | $569mm | 1.05x | +5% |
| 2017 | $542mm | 1.00x | +133% |
| 2016 | $233mm | 0.43x | – |
Other funds from OrbiMed
- Orbimed Private Investments IX, LP 2021
- Orbimed Asia Partners V, LP 2021
- Orbimed Private Investments VIII, LP 2019
- Orbimed Private Investments VII, LP 2017
- Orbimed Asia Partners IV, L.P. 2015
- Orbimed Israel Partners II, L.P. 2015
- Orbimed Private Investments VI, LP 2014
- Orbimed Private Investments V, LP 2013
- Orbimed Asia Partners II, L.P. 2012
- Orbimed Private Investments IV, LP 2011
- Orbimed Private Investments III, LP 2011
- Orbimed Asia Partners, L.P. 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-8033855374. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.